Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,701 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione Cona, Ferrara, Italy
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo Cagliari, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

NCT02450708

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
View Trial Details
Active, Not Recruiting

Mature B-Cell Lymphoma And Leukemia Study III

NCT01046825

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Rady Children's Hospital San Diego San Diego, California, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Children's Cancer Hospital Cairo, Egypt
  • National University Health System Singapore
View Trial Details
Active, Not Recruiting

Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

NCT03319901

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

NCT05456191

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Illinois Cancer Care Peoria, Illinois, United States
  • Regions Hospital Saint Paul, Minnesota, United States
  • Messino Cancer Centers Asheville, North Carolina, United States
View all 120 locations
View Trial Details

Related conditions